Carrie Prowell Pixley
Medical · Watkinsville, GANPI 1871663500
Payments from drug & device makers
Across 408 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$724
- Bayer$550
- Boehringer Ingelheim$524
- Novo Nordisk$521
- Lilly USA, LLC$491
- AstraZeneca$447
- plus $3K from 38 others
What the payments were for
- Food & beverage$6,589100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,589 in reported general payments places this provider in the 85th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $46,700 |
| MounjaroTirzepatide | 20 | $20,017 |
| VraylarCariprazine Hcl | 11 | $15,485 |
| JardianceEmpagliflozin | 13 | $14,758 |
| MyrbetriqMirabegron | 23 | $11,476 |
| NexiumEsomeprazole Magnesium | 13 | $3,317 |
| Telmisartan | 52 | $1,813 |
| Levothyroxine Sodium | 201 | $1,572 |
| Nebivolol Hcl | 25 | $1,289 |
| Rosuvastatin Calcium | 162 | $1,255 |
| Omeprazole | 130 | $1,136 |
| Gabapentin | 82 | $1,074 |
| Valsartan | 31 | $939 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $874 |
| Duloxetine Hcl | 43 | $596 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $521 | $46,70039 claims |
| Lilly USA, LLCMounjaro | $491 | $20,01720 claims |
| AbbVieVraylar, Synthroid | $724 | $16,00626 claims |
| Boehringer IngelheimJardiance | $524 | $14,75813 claims |
| Astellas Pharma US IncMyrbetriq | $43 | $11,47623 claims |
| AstraZenecaNexium | $447 | $3,31713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 950 medical providers in Georgia.
Other medical in Watkinsville
- Elena FercilienWatkinsville$71K
- Michael BoydWatkinsville$42K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.